Nephron Downgrades Edwards Lifesciences (EW) to Hold
Nephron analyst Chris Pasquale downgraded Edwards Lifesciences (NYSE: EW) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
